NEW YORK (GenomeWeb News) – Becton Dickinson today reported a 6 percent increase year over year in its revenues for fiscal first quarter 2014, while its profits were more than halved.

For the three months ended Dec. 31, 2013, BD posted revenues of $2.02 billon, compared to $1.90 billion a year ago, and beating the average analyst estimate of $1.98 billion. In a statement, the firm said that revenue growth came partly from favorable timing of orders in the BD Medical and BD Diagnostics segments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.